IBDEI0MJ ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10504,1,4,0)
 ;;=4^H43.22
 ;;^UTILITY(U,$J,358.3,10504,2)
 ;;=^5005943
 ;;^UTILITY(U,$J,358.3,10505,0)
 ;;=H43.23^^44^505^28
 ;;^UTILITY(U,$J,358.3,10505,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10505,1,3,0)
 ;;=3^Crystalline Deposits in Vitreous Body,Bilateral
 ;;^UTILITY(U,$J,358.3,10505,1,4,0)
 ;;=4^H43.23
 ;;^UTILITY(U,$J,358.3,10505,2)
 ;;=^5005944
 ;;^UTILITY(U,$J,358.3,10506,0)
 ;;=H43.11^^44^505^119
 ;;^UTILITY(U,$J,358.3,10506,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10506,1,3,0)
 ;;=3^Vitreous Hemorrhage,Right Eye
 ;;^UTILITY(U,$J,358.3,10506,1,4,0)
 ;;=4^H43.11
 ;;^UTILITY(U,$J,358.3,10506,2)
 ;;=^5005938
 ;;^UTILITY(U,$J,358.3,10507,0)
 ;;=H43.12^^44^505^118
 ;;^UTILITY(U,$J,358.3,10507,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10507,1,3,0)
 ;;=3^Vitreous Hemorrhage,Left Eye
 ;;^UTILITY(U,$J,358.3,10507,1,4,0)
 ;;=4^H43.12
 ;;^UTILITY(U,$J,358.3,10507,2)
 ;;=^5005939
 ;;^UTILITY(U,$J,358.3,10508,0)
 ;;=H43.391^^44^505^122
 ;;^UTILITY(U,$J,358.3,10508,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10508,1,3,0)
 ;;=3^Vitreous Opacities,Right Eye NEC
 ;;^UTILITY(U,$J,358.3,10508,1,4,0)
 ;;=4^H43.391
 ;;^UTILITY(U,$J,358.3,10508,2)
 ;;=^5005949
 ;;^UTILITY(U,$J,358.3,10509,0)
 ;;=H43.392^^44^505^121
 ;;^UTILITY(U,$J,358.3,10509,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10509,1,3,0)
 ;;=3^Vitreous Opacities,Left Eye NEC
 ;;^UTILITY(U,$J,358.3,10509,1,4,0)
 ;;=4^H43.392
 ;;^UTILITY(U,$J,358.3,10509,2)
 ;;=^5005950
 ;;^UTILITY(U,$J,358.3,10510,0)
 ;;=H43.393^^44^505^120
 ;;^UTILITY(U,$J,358.3,10510,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10510,1,3,0)
 ;;=3^Vitreous Opacities,Bilateral NEC
 ;;^UTILITY(U,$J,358.3,10510,1,4,0)
 ;;=4^H43.393
 ;;^UTILITY(U,$J,358.3,10510,2)
 ;;=^5005951
 ;;^UTILITY(U,$J,358.3,10511,0)
 ;;=H43.01^^44^505^125
 ;;^UTILITY(U,$J,358.3,10511,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10511,1,3,0)
 ;;=3^Vitreous Prolapse,Right Eye
 ;;^UTILITY(U,$J,358.3,10511,1,4,0)
 ;;=4^H43.01
 ;;^UTILITY(U,$J,358.3,10511,2)
 ;;=^5005934
 ;;^UTILITY(U,$J,358.3,10512,0)
 ;;=H43.02^^44^505^124
 ;;^UTILITY(U,$J,358.3,10512,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10512,1,3,0)
 ;;=3^Vitreous Prolapse,Left Eye
 ;;^UTILITY(U,$J,358.3,10512,1,4,0)
 ;;=4^H43.02
 ;;^UTILITY(U,$J,358.3,10512,2)
 ;;=^5005935
 ;;^UTILITY(U,$J,358.3,10513,0)
 ;;=H43.03^^44^505^123
 ;;^UTILITY(U,$J,358.3,10513,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10513,1,3,0)
 ;;=3^Vitreous Prolapse,Bilateral
 ;;^UTILITY(U,$J,358.3,10513,1,4,0)
 ;;=4^H43.03
 ;;^UTILITY(U,$J,358.3,10513,2)
 ;;=^5005936
 ;;^UTILITY(U,$J,358.3,10514,0)
 ;;=H43.821^^44^505^114
 ;;^UTILITY(U,$J,358.3,10514,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10514,1,3,0)
 ;;=3^Vitreomacular Adhesion,Right Eye
 ;;^UTILITY(U,$J,358.3,10514,1,4,0)
 ;;=4^H43.821
 ;;^UTILITY(U,$J,358.3,10514,2)
 ;;=^5005957
 ;;^UTILITY(U,$J,358.3,10515,0)
 ;;=H43.822^^44^505^113
 ;;^UTILITY(U,$J,358.3,10515,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10515,1,3,0)
 ;;=3^Vitreomacular Adhesion,Left Eye
 ;;^UTILITY(U,$J,358.3,10515,1,4,0)
 ;;=4^H43.822
 ;;^UTILITY(U,$J,358.3,10515,2)
 ;;=^5005958
 ;;^UTILITY(U,$J,358.3,10516,0)
 ;;=H43.823^^44^505^112
 ;;^UTILITY(U,$J,358.3,10516,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10516,1,3,0)
 ;;=3^Vitreomacular Adhesion,Bilateral
 ;;^UTILITY(U,$J,358.3,10516,1,4,0)
 ;;=4^H43.823
 ;;^UTILITY(U,$J,358.3,10516,2)
 ;;=^5005959
 ;;^UTILITY(U,$J,358.3,10517,0)
 ;;=H35.353^^44^505^31
 ;;^UTILITY(U,$J,358.3,10517,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10517,1,3,0)
 ;;=3^Cystoid Macular Degeneration,Bilateral
